Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Scherbakov

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Research in Pharmaceutical Sciences|October 16, 2023
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metforminEkaterina I Mikhaevich, Danila V Sorokin, Alexander M Scherbakov
Journal of Cellular Biochemistry|February 7, 2012
The relationships between snail1 and estrogen receptor signaling in breast cancer cellsAlexander M Scherbakov, Olga E Andreeva, Valentina A Shatskaya, et al.
Steroids|May 12, 2009
The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signalingAlexander M Scherbakov, Yulia S Lobanova, Valentina A Shatskaya, et al.
RSC Advances|May 2, 2022
Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cellsGalina I Buravchenko, Alexander M Scherbakov, Lyubov G Dezhenkova, et al.
Natural Product Research|October 7, 2020
Antiestrogenic and antiproliferative potency of secoisolariciresinol diglucoside derivatives on MCF-7 breast cancer cellsAlexander M Scherbakov, Olga V Stasevich, Diana I Salnikova, et al.
Current Organic Synthesis|February 28, 2020
Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia SelectivityGalina I Buravchenko, Alexander M Scherbakov, Alexander А Korlukov, et al.
Biochimie|April 19, 2021
Glucose starvation greatly enhances antiproliferative and antiestrogenic potency of oligomycin A in MCF-7 breast cancer cellsAlexander M Scherbakov, Danila V Sorokin, Olga A Omelchuk, et al.
Bioscience Reports|July 29, 2010
Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicinAlexander M Scherbakov, Yulia S Lobanova, Olga E Andreeva, et al.
Anticancer Research|July 26, 2007
Phosphatidylinositol 3-kinase/AKT signalling pathway components in human breast cancer: clinicopathological correlationsElena S Gershtein, Alexander M Scherbakov, Valentina A Shatskaya, et al.
Irish Journal of Medical Science|November 6, 2021
The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?Tatiana A Bogush, Anna A Basharina, Elena A Bogush, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Research in Pharmaceutical Sciences|October 16, 2023
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metforminEkaterina I Mikhaevich, Danila V Sorokin, Alexander M Scherbakov
Journal of Cellular Biochemistry|February 7, 2012
The relationships between snail1 and estrogen receptor signaling in breast cancer cellsAlexander M Scherbakov, Olga E Andreeva, Valentina A Shatskaya, et al.
Steroids|May 12, 2009
The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signalingAlexander M Scherbakov, Yulia S Lobanova, Valentina A Shatskaya, et al.
RSC Advances|May 2, 2022
Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cellsGalina I Buravchenko, Alexander M Scherbakov, Lyubov G Dezhenkova, et al.
Natural Product Research|October 7, 2020
Antiestrogenic and antiproliferative potency of secoisolariciresinol diglucoside derivatives on MCF-7 breast cancer cellsAlexander M Scherbakov, Olga V Stasevich, Diana I Salnikova, et al.
Current Organic Synthesis|February 28, 2020
Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia SelectivityGalina I Buravchenko, Alexander M Scherbakov, Alexander А Korlukov, et al.
Biochimie|April 19, 2021
Glucose starvation greatly enhances antiproliferative and antiestrogenic potency of oligomycin A in MCF-7 breast cancer cellsAlexander M Scherbakov, Danila V Sorokin, Olga A Omelchuk, et al.
Bioscience Reports|July 29, 2010
Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicinAlexander M Scherbakov, Yulia S Lobanova, Olga E Andreeva, et al.
Anticancer Research|July 26, 2007
Phosphatidylinositol 3-kinase/AKT signalling pathway components in human breast cancer: clinicopathological correlationsElena S Gershtein, Alexander M Scherbakov, Valentina A Shatskaya, et al.
Irish Journal of Medical Science|November 6, 2021
The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?Tatiana A Bogush, Anna A Basharina, Elena A Bogush, et al.
Pageof 7